CIBC Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,536
Closed -$295K 1469
2022
Q1
$295K Hold
2,536
﹤0.01% 1075
2021
Q4
$382K Buy
2,536
+84
+3% +$11.3K ﹤0.01% 942
2021
Q3
$293K Buy
2,452
+171
+7% +$18.8K ﹤0.01% 1035
2021
Q2
$222K Hold
2,281
﹤0.01% 1214
2021
Q1
$201K Buy
2,281
+73
+3% +$6.78K ﹤0.01% 1257
2020
Q4
$211K Hold
2,208
﹤0.01% 1118
2020
Q3
$251K Buy
2,208
+54
+3% +$5.67K ﹤0.01% 903
2020
Q2
$213K Buy
+2,154
New +$172K ﹤0.01% 952

Other funds holding TNDM

CIBC Asset Management's TNDM Position: Q2 2022 in Review

CIBC Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,536 shares — an estimated $295K sold.

CIBC Asset Management first reported a position in TNDM in Q2 2020 and held it in 8 quarters. The position peaked at $382K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • CIBC Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • CIBC Asset Management sold 2,536 Tandem Diabetes Care shares in Q2 2022, an estimated $295K.
  • CIBC Asset Management first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 8 quarters.
  • CIBC Asset Management's Tandem Diabetes Care position peaked at $382K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.